Compare AdaptHealth Corp (AHCO) vs iShares MSCI Taiwan ETF (EWT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs iShares MSCI Taiwan ETF — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while iShares MSCI Taiwan ETF trades at $103.79. The key difference: iShares MSCI Taiwan ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | EWT | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $111.53 |
52-Week Low | $8.68 | $57.66 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
EWT trades at $107.27, up 2.3% with strong bullish momentum from moving averages. The ETF has more than doubled in the past year, driven by Taiwan's semiconductor sector dominance and AI infrastructure demand. Technical indicators show neutral oscillators but overall buy signals dominate. Recent news highlights geopolitical tensions and semiconductor supply chain importance as key drivers.
Outlook remains positive given Taiwan's critical role in global tech supply chains, though stretched valuations and China-Taiwan geopolitical risks pose significant headwinds. The concentration in tech stocks like TSMC offers growth exposure but increases vulnerability to sector-specific downturns and trade disruptions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →
